Preparation of co-crystals of human PPARα-LBD and ligand for high-resolution X-ray crystallography. 2021

Shotaro Kamata, and Takuji Oyama, and Isao Ishii
Department of Health Chemistry, Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.

Peroxisome proliferator-activated receptors (PPARs) are nuclear receptor-type transcription factors with three subtypes (α, δ, and γ) that regulate cell differentiation and metabolism. Co-crystals of human PPARα-ligand-binding domain (LBD)-PPARα ligand for X-ray crystallography have been difficult to obtain. Recombinant human PPARα-LBD proteins contain intrinsic fatty acids (iFAs of Escherichia coli origin) and may be unstable without ligands during crystallization. To circumvent these limitations, we have successfully applied various crystallization techniques, including co-crystallization, cross-seeding, soaking, delipidation, and coactivator peptide supplementation. For complete details on the use and execution of this protocol, please refer to Kamata et al. (2020).

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D003460 Crystallization The formation of crystalline substances from solutions or melts. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Crystalline Polymorphs,Polymorphism, Crystallization,Crystal Growth,Polymorphic Crystals,Crystal, Polymorphic,Crystalline Polymorph,Crystallization Polymorphism,Crystallization Polymorphisms,Crystals, Polymorphic,Growth, Crystal,Polymorph, Crystalline,Polymorphic Crystal,Polymorphisms, Crystallization,Polymorphs, Crystalline
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072417 Protein Domains Discrete protein structural units that may fold independently of the rest of the protein and have their own functions. Peptide Domain,Protein Domain,Domain, Peptide,Domain, Protein,Domains, Peptide,Domains, Protein,Peptide Domains
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D047493 PPAR alpha A nuclear transcription factor. Heterodimerization with RETINOID X RECEPTOR GAMMA is important to metabolism of LIPIDS. It is the target of FIBRATES to control HYPERLIPIDEMIAS. PPARalpha,Peroxisome Proliferator-Activated Receptor alpha,Peroxisome Proliferator Activated Receptor alpha

Related Publications

Shotaro Kamata, and Takuji Oyama, and Isao Ishii
January 2021, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Shotaro Kamata, and Takuji Oyama, and Isao Ishii
April 2009, Annals of the New York Academy of Sciences,
Shotaro Kamata, and Takuji Oyama, and Isao Ishii
January 2010, Methods in enzymology,
Shotaro Kamata, and Takuji Oyama, and Isao Ishii
January 2005, Methods in molecular biology (Clifton, N.J.),
Shotaro Kamata, and Takuji Oyama, and Isao Ishii
May 1968, Journal of scientific instruments,
Shotaro Kamata, and Takuji Oyama, and Isao Ishii
August 1985, The Journal of biological chemistry,
Shotaro Kamata, and Takuji Oyama, and Isao Ishii
January 2022, Methods in enzymology,
Shotaro Kamata, and Takuji Oyama, and Isao Ishii
October 2000, Acta crystallographica. Section D, Biological crystallography,
Shotaro Kamata, and Takuji Oyama, and Isao Ishii
January 2013, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!